First human trial of ETD-001 gel begins safety testing
NCT ID NCT07674862
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This early-stage trial tests the safety and tolerability of ETD-001 gel in healthy Chinese adults aged 18 to 60. Participants receive either the gel or a placebo, with doses increased gradually. The study aims to understand how the body processes the gel and whether it causes any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ETD-001 gel
What this could lead to
If safe and well-tolerated, this could pave the way for future studies testing ETD-001 gel for medical conditions.
What could go wrong
This is an early Phase 1 trial with only 56 healthy participants, so results may not predict effectiveness or safety in patients. Side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SAFETY ISSUES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hangzhou
Hangzhou, Zhejiang, China